Ohio State leads multi-million dollar research on long COVID solutions

FHS
July 24, 2024
2:47 am

A 2022 study suggesting that blocking a single molecule could protect against severe illness in COVID-19 has led to a $15 million federal grant supporting a comprehensive effort to learn more – with finding a solution to long COVID at the center of the new research.

Fulcrum, CAMP4 sign deal to develop blood disorder therapies

DBA is caused by genetic changes in ribosomal sub-units that stop the maturation of red blood cells. Credit: ANIRUDH on Unsplash. Fulcrum Therapeutics has signed

July 11, 2023

Psychedelics Reform Update From Several States In The Union

Since our previous roundup, whether inside state legislatures or out on the streets, there’s been some consistent movement of proposals concerning psychedelics. As of Sept. 28: Massachusetts:

October 2, 2023

Which COVID Strain Is Expected to Take Over in the Coming Months?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

September 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.